Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

MMP inhibitors from Warner-Lambert particularly active against MMP-2, MMP-3 and MMP-13

March 3, 2000

Large valsartan trial reaches enrollment objectives

March 3, 2000

Potential role for perillyl alcohol in cardiovascular disease

March 2, 2000

Pharmacyclics initiates phase I clinical trial of Antrin for treatment of coronary artery disease

March 2, 2000

FDA puts VEGF-2 trials on hold

March 2, 2000

EGF-genistein: a new pharmacological approach to treating, preventing restenosis

March 2, 2000

Effects of homocysteine lowering with vitamins on subclinical atherosclerosis

March 2, 2000

Myogen and UT Southwestern Medical Center collaborate on heart failure treatment

March 2, 2000

Role of dietary factors discussed at cardiovascular disease conference

March 1, 2000

Tulane team studies gene therapy for pulmonary hypertension

Feb. 29, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...